Top

International Journal of Clinical Oncology

Published in:

01-04-2011 | Case Report

Full-thickness chest-wall resection followed by thorax reconstruction for recurrent malignant phyllodes tumor

Authors: Tokiko Ito, Ken-ichi Ito, Toshihiro Okada, Koichi Murayama, Toru Hanamura, Toshiharu Kanai, Kazuma Maeno, Yasuhiro Mochizuki, Ryoichi Kondo, Jun Amano, Yoshiro Osada, Koji Asano

Published in: International Journal of Clinical Oncology | Issue 2/2011

Abstract

We present a case of a 39-year-old woman with a giant recurrent malignant phyllodes tumor accompanied with bleeding and infection. She underwent full-thickness chest-wall resection. Bony thorax reconstruction and stabilization was accomplished using a Composix mesh™, and soft tissue reconstruction was performed with a musculocutaneous flap of latissimus dorsi muscle. The patient had a good postoperative outcome, and the surgical treatment remarkably improved her quality of life. Because chemotherapy and radiation are not established for treating malignant phyllodes tumors, an aggressive surgical approach should be considered for patients with a locally advanced malignant phyllodes tumor.

Grimes MM (1992) Cystosarcoma phyllodes of the breast: histological features flow cytometric analysis, and clinical correlations. Mod Pathol 5:232–239PubMed

Kleer CG, Giordano TJ, Braun T (2001) Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast. Mod Pathol 14:185–190PubMedCrossRef

Parker SJ, Harries SA (2001) Phyllodes tumours. Postgrad Med J 77:428–435PubMedCrossRef

Khan SA, Badve S (2001) Phyllodes tumors of the breast. Curr Treat Options Oncol 2:139–147PubMedCrossRef

Santillan AA, Kiluk JV, Cox JM (2008) Outcomes of locoregional recurrence after surgical chest wall resection and reconstruction for breast cancer. Ann Surg Oncol 15:1322–1329PubMedCrossRef

Pameijer CR, Smith D, McCahill LE (2005) Full-thickness chest wall resection for recurrent breast carcinoma: an institutional review and meta-analysis. Am Surg 71:711–715PubMed

Povoski SP, Marsh WL Jr, Spigos DG (2006) Management of a patient with multiple recurrences of fibromatosis (desmoid tumor) of the breast involving the chest wall musculature. World J Surg Oncol 4:32PubMedCrossRef

Andrade Neto JD, Terra RM, Fernandez A et al (2007) Full-thickness chest wall resection for recurrent breast phyllodes tumor. Ann Thorac Surg 83:2196–2197PubMedCrossRef

Hart WR, Bauer RC, Oberman HA (1978) Cystosarcoma phyllodes. A clinicopathologic study of twenty-six hypercellular periductal stromal tumors of the breast. Am J Clin Pathol 70:211–216PubMed

10.

Takahashi M, Murata K, Mori M et al (1992) Giant metastatic cystosarcoma phyllodes to the lung: CT and MR findings. Radiat Med 10:210–213PubMed

11.

Filosso PL, Turello D, Pernazza F et al (2005) Radical surgical resection of a giant pleural metastasis of a malignant phyllodes tumor of the breast. J Thorac Cardiovasc Surg 130:1707–1708PubMedCrossRef

12.

Ganti S, Svennevik E, Ali FSM et al (2007) Successful resection of giant solitary pulmonary metastasis from a phyllodes tumor. Ann Thorac Surg 84:1750–1752PubMedCrossRef

13.

Yoshida K, Kobayashi N, Kurai M et al (2006) A subtotal sternectomy successfully reconstructed with Composix mesh. Ann Thorac Cardiovasc Surg 12:420–424PubMed

14.

Hirai S, Nobuto H, Yokota K et al (2009) Surgical resection and reconstruction for primary malignant sternal tumor. Ann Thorac Cardiovasc Surg 15:182–185PubMed

Title: Full-thickness chest-wall resection followed by thorax reconstruction for recurrent malignant phyllodes tumor
Authors: Tokiko Ito
Ken-ichi Ito
Toshihiro Okada
Koichi Murayama
Toru Hanamura
Toshiharu Kanai
Kazuma Maeno
Yasuhiro Mochizuki
Ryoichi Kondo
Jun Amano
Yoshiro Osada
Koji Asano
Publication date: 01-04-2011
Publisher: Springer Japan
Published in: International Journal of Clinical Oncology / Issue 2/2011
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-010-0117-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2011

Questionnaire survey of the current status of radical trachelectomy in Japan

Cryoimmunology for malignant bone and soft-tissue tumors

Tumor imaging with multicolor fluorescent protein expression

An inconspicuous fallopian-tube carcinoma clinically manifested as a rectovaginal septal tumor: a pitfall for diagnosis and treatment

Basic science and clinical frontiers of sarcoma treatment

Metastatic collecting duct carcinoma of the kidney responded to sunitinib

Keynote webinar | Spotlight on antibody–drug conjugates in cancer